THE OPPORTUNITY The way brands are discovered online is changing as search engines, AI assistants, and large language models increasingly shape how users find information and interact with content. Adobe’s Domain Experts team operates where SEO,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Manager: Global Membership Communications, IBBY Programmes, & Strategic Advocacy Department: International Board on Books for Young People Secretariat. Location: Basel, Switzerland (100%, In-Office). Strategic Mandate: To increase IBBY’s global advocacy and operational capabilities by leveraging deep institutional
Viking (NYSE: VIK) was founded in 1997 and provides destination-focused journeys on rivers, oceans and lakes around the world. Designed for curious travelers with interests in science, history, culture and cuisine, Chairman and CEO Torstein Hagen
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)